Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc.
Acquiring Company
Nanoscope Therapeutics
Acquired Company
Warrants
Dallas
FranceDallasBiotechnologyHealth CareMedicalTherapeuticsBiotechnologyHealth CareMedicalTherapeuticsDescription
Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, announced the consummation of the previously announced purchase of securities from Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”).
Quick answer
Nanoscope Therapeutics is acquiring Warrants and Nanoscope Therapeutics, announced September 21, 2023. Nanoscope Therapeutics is based in Dallas, Texas, United States.
- How much did Nanoscope Therapeutics pay for Warrants?
- The deal value was not disclosed.
- What does Nanoscope Therapeutics do?
- Nanoscope Therapeutics is developing mutation-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases for which no treatment currently exists.
- Where are Nanoscope Therapeutics and Warrants based?
- Nanoscope Therapeutics is based in Dallas, Texas, United States. Warrants is based in France.
- Who are the decision-makers at Nanoscope Therapeutics?
- Fundz holds 2 contacts at Nanoscope Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Airlife Completes Acquisition Of Avanos Medical’S Respiratory Health Business (October 2, 2023)
- Regeneron Completes Acquisition Of Decibel Therapeutics, Adding Promising Gene Therapy Programs For Hearing Loss (September 25, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Labgenomics Usa Llc Acquires Qdx Pathology In A Strategic Move To Expand Its Diagnostic Lab Services And Ivd Diagnostic Products Business Into The Us Market (September 5, 2023)
- Rqm+™ Acquires Germany Based Cro Kottmann (August 28, 2023)
Who to call at Nanoscope Therapeutics, and when
When Nanoscope Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Nanoscope Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nanoscope Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nanoscope Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nanoscope Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Warrants?
Warrants was acquired by Nanoscope Therapeutics, based in Dallas. The deal was reported on September 21, 2023. Nanoscope Therapeutics is developing mutation-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases for which no treatment currently exists. Nanoscope Therapeutics is privately held and operates in Biotechnology.
When did Nanoscope Therapeutics acquire Warrants?
Nanoscope Therapeutics's acquisition of Warrants was reported on September 21, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Warrants do?
This website is for sale! warrants.fr is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, warrants.fr has it all. We hope you find what you are searching for! It is privately held, and is based in France.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.